Proscia
@Proscia
Followers
1K
Following
2K
Media
1K
Statuses
3K
Proscia is fighting cancer by changing the way the world practices pathology. Join us.
Philadelphia, PA
Joined October 2013
We asked AI to observe the pathologist in it's natural habitat. How did it do?
0
0
5
Biopharma teams aren’t debating whether to invest in digital pathology + AI; they’re scaling with intent to:. – Move trials faster. – Improve read quality. – Turn proprietary data into a compounding advantage. Learn more in a webinar hosted by @DDWJournal w/ our CSO
0
0
4
Why this matters: By removing dependencies on large tissue volumes and high-cost sequencing, an H&E-native AI biomarker helps democratize companion diagnostics, expanding global trial participation and patient access to advanced therapies.
1
0
2
Used alongside PD-L1, Deep-IO sharply enriches the responder group - ~51% for combined positives - vs ~25–30% overall response to checkpoint therapy today.
1
0
1
JAMA Oncology: Deep-IO, a deep learning model on routine H&E from 958 advanced NSCLC cases, predicts who benefits from immune checkpoint inhibitors. It matches PD-L1 on overall performance and yields ~10-point higher specificity.
jamanetwork.com
This multicenter cohort study develops and assesses the validity of a deep learning model for predicting immune checkpoint inhibitor response in patients with advanced non−small cell lung cancer.
1
1
3
Check-in: @pathologistmag revisited January’s #digitalpathology + AI predictions (spoiler: they’re showing up in the wild). We loved seeing plenty of familiar voices in the mix from our own @Nate_Buchbinder, customers, partners, + industry friends.
thepathologist.com
What has shifted in the digital pathology and AI space since the start of 2025? Our experts reflect on the accuracy of their January forecasts.
0
0
5
Deep LIS integration is the long-term goal of a #digitalpathology transformation. This is why we've prioritized interoperability from day one—recently announcing the integration of Concentriq w/ 100+ LIS instances, including CoPath, Epic Beaker, NovoPath, LigoLab, + Orchard
0
0
3
It’s not every day that lab leaders overwhelmingly agree—but in a recent survey, 86% said precision medicine has moved beyond the hype, with AI-driven #pathology playing a pivotal role in that evolution. Our CSO @Nate_Buchbinder breaks down what this shift means for the future
0
0
6
Pathology AI is advancing the work of those on the forefront of precision medicine: our customers. Below, @davidwest_irl joins @RS_flinn on @BiotechTV to talk shop.
𝐀𝐈 𝐱 𝐁𝐢𝐨 𝐒𝐮𝐦𝐦𝐢𝐭: @Proscia CEO @davidwest_irl describes how AI in pathology is not just helping pathologists find disease, but can also help get the right drug to the right patient. Full video:
0
3
12
Nonlinear path > cookie‑cutter resume. Learn more about what makes Frank Grullon, our Diagnostic Platform Engineering Manager, an exceptional leader. Catch his Q&A on @Technical_ly. 👇
technical.ly
Today, Frank Grullon manages a team at a major life sciences startup, but it took several pivots to get here.
0
0
4
Behind the scenes of David’s interview with theCUBE + NYSE wired. Live tomorrow:
thecube.net
Join theCUBE + NYSE Wired for MedTech Unplugged, a new series spotlighting the pioneers, disruptors and dealmakers reshaping the future of healthcare. Broadcasting from the New York Stock Exchange,...
0
0
1